Drugplain

frovatriptan succinate 2.5 mg/1

frovatriptan succinate · TABLET, FILM COATED · Glenmark Pharmaceuticals Inc., USA

No Recall History
Plain English

frovatriptan succinate is a tablet, film coated containing frovatriptan succinate at 2.5 mg/1, taken oral. Manufactured by Glenmark Pharmaceuticals Inc., USA.

Key Facts

Brand Name
frovatriptan succinate
Generic Name
frovatriptan succinate
NDC Code (Product)
68462-694
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Strength
2.5 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
ANDA204730
Marketing Start
03/11/2016

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective for unapproved indication151 reports
off label use143 reports
headache133 reports
drug ineffective123 reports
drug intolerance119 reports
hypersensitivity114 reports
angioedema110 reports
dysphonia110 reports
swelling face110 reports
swollen tongue110 reports

Frequently Asked Questions

What is frovatriptan succinate used for?

frovatriptan succinate contains frovatriptan succinate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.

Is frovatriptan succinate a controlled substance?

frovatriptan succinate is not classified as a controlled substance by the DEA.

What is the generic name for frovatriptan succinate?

The generic name for frovatriptan succinate is frovatriptan succinate. There are 2 other brand versions of frovatriptan succinate.

What is the NDC code for frovatriptan succinate 2.5 mg/1?

The NDC (National Drug Code) for frovatriptan succinate 2.5 mg/1 is 68462-694, listed by Glenmark Pharmaceuticals Inc., USA.

Product NDC

68462-694

Package NDC

68462-694-97

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)